XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.4
Stockholders' Equity - Warrants (Details) - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended 15 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Sep. 30, 2024
May 15, 2023
Other disclosures              
Compensation expense $ 150,000   $ 320,000 $ 170,000      
Purchaseable stock 23,581,290   23,581,290   19,795,053 23,581,290  
Warrants              
Number of Other than Options              
Outstanding and exercisable, beginning balance (in shares)     1,116,065        
Issued (in shares)     182,952        
Exercised (in shares)     0        
Expired/Forfeited (in shares)     (115,000)        
Outstanding, ending balance (in shares) 1,184,017   1,184,017   1,116,065 1,184,017  
Exercisable (in shares) 184,017   184,017     184,017  
Weighted Average Exercise Price              
Outstanding and exercisable, beginning balance (in dollars per share)     $ 1.67        
Issued (in dollars per share)     0.81        
Exercised (in dollars per share)     0        
Expired/Forfeited (in dollars per share)     3.17        
Outstanding, ending balance (in dollars per share) $ 1.39   1.39   $ 1.67 $ 1.39  
Exercisable, ending balance (in dollars per share) $ 0.81   $ 0.81     $ 0.81  
Weighted Average Remaining Contractual Life (in Years), Outstanding     7 years 11 months 23 days   8 years 5 months 15 days    
Weighted Average Contractual Life (in Years), Exercisable     4 years 5 months 8 days        
Aggregate Intrinsic Value, Outstanding $ 0   $ 0   $ 0 $ 0  
Aggregate Intrinsic Value, Exercisable 0   0     0  
Other disclosures              
Compensation expense $ 0 $ 0 0 0      
Warrants | Halston License              
Other disclosures              
Warrant term             10 years
Purchaseable stock             1,000,000
Warrants outstanding, exercise price (in dollars per share)             $ 1.50
Contra-revenue related to warrants held by licensee     $ 30,000.00 $ 20,000.00   $ 10,000.00  
Number of shares vested     0